Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 13, 2026

ATOS — Atossa Therapeutics, Inc. Dilution Risk Tracker

Track ATOS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ATOS — Get alerts when the score changes →

As of October 13, 2026, Atossa Therapeutics, Inc. (ATOS) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Atossa Therapeutics, Inc. has a market capitalization of $23.84M, 9.98M shares outstanding, 3 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 16%
💰 Capital Raise model 33%
• Under 12 months cash (12mo)
• Active ATM program with $100M remaining capacity
🔔 Track ATOS — Get forecast alerts →

Market Data

Market Cap$23.84M
Shares Outstanding9.98M
Float8.58M
Cash$26.09M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding9.98MVerified float table or market cache
Public Float8.58MVerified float table or market cache
Market Cap$23.84MMarket data cache
Cash Runway11.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 2, 424B3 1, 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 96.1% shares (2026Q1 vs prior)
3 institutional holders · 878.9K shares
#1 BARCLAYS PLC 700.0K shares
#2 MORGAN STANLEY 173.8K shares
#3 Rockefeller Capital Management L.P. 5.0K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest788.3K
Days to Cover11.3
% of Float9.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-07
xbrl XBRL CONVERTIBLE 2026-03-25
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-30
8-K 8K EVENT 2026-02-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ATOS Dilution Snapshot

Atossa Therapeutics, Inc. (ATOS) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ATOS's DilutionScore is currently 52/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 62/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202652/100HIGH13 days
Aug 22 – Sep 30, 202662/100HIGH40 days
Aug 14 – Aug 21, 202644/100MEDIUM7 days
Jul 16 – Aug 13, 202654/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track ATOS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ATOS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ATOS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ATOS
ATOS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.